Cargando…

Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series

BACKGROUND: Bartonella are gram-negative bacilli not identified by routine bacterial culture. The objectives of this study were to review the results of all serologic testing for Bartonella ordered in Manitoba, Canada, and to review cases with positive test results among adults to assess species ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Boodman, Carl, Wuerz, Terence, Lagacé-Wiens, Philippe, Lindsay, Robbin, Dibernardo, Antonia, Bullard, Jared, Stein, Derek R., Keynan, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177198/
https://www.ncbi.nlm.nih.gov/pubmed/35640989
http://dx.doi.org/10.9778/cmajo.20210180
_version_ 1784722837048655872
author Boodman, Carl
Wuerz, Terence
Lagacé-Wiens, Philippe
Lindsay, Robbin
Dibernardo, Antonia
Bullard, Jared
Stein, Derek R.
Keynan, Yoav
author_facet Boodman, Carl
Wuerz, Terence
Lagacé-Wiens, Philippe
Lindsay, Robbin
Dibernardo, Antonia
Bullard, Jared
Stein, Derek R.
Keynan, Yoav
author_sort Boodman, Carl
collection PubMed
description BACKGROUND: Bartonella are gram-negative bacilli not identified by routine bacterial culture. The objectives of this study were to review the results of all serologic testing for Bartonella ordered in Manitoba, Canada, and to review cases with positive test results among adults to assess species identification, risk factors, clinical manifestations and outcomes. METHODS: This retrospective study included all Bartonella serologic tests ordered in Manitoba and performed at the National Microbiology Laboratory, Winnipeg, from Jan. 1, 2010, until Dec. 31, 2020. We analyzed the aggregate data for all serologic tests for Bartonella for patients of all ages. We reviewed the charts of adult (age ≥ 18 yr) patients with serologic positivity for Bartonella who had a medical chart at 1 of Winnipeg’s 2 largest hospitals (Health Sciences Centre and St. Boniface Hospital) to extract clinical and demographic data and create a case series. Descriptive statistics were performed. RESULTS: During the study period, 1014 Bartonella serologic tests were ordered in adult and pediatric patients, of which 24 (2.4%) gave a positive result. Sixteen adults (12 men and 4 women; mean age 48 yr) seen at a participating hospital had a positive result. Molecular species-level identification occurred on explanted cardiac valves in 5 (31%) of the 16 cases; B. quintana was identified in all 5. Six patients (38%) were diagnosed with probable B. quintana infection, for a total of 11 B. quintana cases (69%); 8 (73%) of the 11 had endocarditis. Four cases of B. quintana infection (36%) were associated with rural residence. Four cases (25%) of probable B. henselae were identified; 2 patients had fever and lymphadenopathy, and 2 had endocarditis. The remaining patient was deemed to have a false-positive result as his B. henselae titre was at the threshold for positivity, his B. quintana serologic test gave a negative result, and his clinical syndrome was not suggestive of Bartonella infection. Two patients died; both had multivalvular B. quintana endocarditis with ruptured intracranial mycotic aneurysms. INTERPRETATION: Bartonella quintana was a common cause of Bartonella serologic positivity among adults in Manitoba in 2010–2020 and was associated with endocarditis and systemic embolization. As B. quintana is transmitted by body lice, active case finding for people who lack suitable housing, both in urban and rural settings, should prioritize those with elevated Bartonella titres to receive echocardiography and detect endocarditis before systemic embolization occurs.
format Online
Article
Text
id pubmed-9177198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-91771982022-06-12 Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series Boodman, Carl Wuerz, Terence Lagacé-Wiens, Philippe Lindsay, Robbin Dibernardo, Antonia Bullard, Jared Stein, Derek R. Keynan, Yoav CMAJ Open Research BACKGROUND: Bartonella are gram-negative bacilli not identified by routine bacterial culture. The objectives of this study were to review the results of all serologic testing for Bartonella ordered in Manitoba, Canada, and to review cases with positive test results among adults to assess species identification, risk factors, clinical manifestations and outcomes. METHODS: This retrospective study included all Bartonella serologic tests ordered in Manitoba and performed at the National Microbiology Laboratory, Winnipeg, from Jan. 1, 2010, until Dec. 31, 2020. We analyzed the aggregate data for all serologic tests for Bartonella for patients of all ages. We reviewed the charts of adult (age ≥ 18 yr) patients with serologic positivity for Bartonella who had a medical chart at 1 of Winnipeg’s 2 largest hospitals (Health Sciences Centre and St. Boniface Hospital) to extract clinical and demographic data and create a case series. Descriptive statistics were performed. RESULTS: During the study period, 1014 Bartonella serologic tests were ordered in adult and pediatric patients, of which 24 (2.4%) gave a positive result. Sixteen adults (12 men and 4 women; mean age 48 yr) seen at a participating hospital had a positive result. Molecular species-level identification occurred on explanted cardiac valves in 5 (31%) of the 16 cases; B. quintana was identified in all 5. Six patients (38%) were diagnosed with probable B. quintana infection, for a total of 11 B. quintana cases (69%); 8 (73%) of the 11 had endocarditis. Four cases of B. quintana infection (36%) were associated with rural residence. Four cases (25%) of probable B. henselae were identified; 2 patients had fever and lymphadenopathy, and 2 had endocarditis. The remaining patient was deemed to have a false-positive result as his B. henselae titre was at the threshold for positivity, his B. quintana serologic test gave a negative result, and his clinical syndrome was not suggestive of Bartonella infection. Two patients died; both had multivalvular B. quintana endocarditis with ruptured intracranial mycotic aneurysms. INTERPRETATION: Bartonella quintana was a common cause of Bartonella serologic positivity among adults in Manitoba in 2010–2020 and was associated with endocarditis and systemic embolization. As B. quintana is transmitted by body lice, active case finding for people who lack suitable housing, both in urban and rural settings, should prioritize those with elevated Bartonella titres to receive echocardiography and detect endocarditis before systemic embolization occurs. CMA Impact Inc. 2022-05-31 /pmc/articles/PMC9177198/ /pubmed/35640989 http://dx.doi.org/10.9778/cmajo.20210180 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Boodman, Carl
Wuerz, Terence
Lagacé-Wiens, Philippe
Lindsay, Robbin
Dibernardo, Antonia
Bullard, Jared
Stein, Derek R.
Keynan, Yoav
Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title_full Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title_fullStr Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title_full_unstemmed Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title_short Serologic testing for Bartonella in Manitoba, Canada, 2010–2020: a retrospective case series
title_sort serologic testing for bartonella in manitoba, canada, 2010–2020: a retrospective case series
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177198/
https://www.ncbi.nlm.nih.gov/pubmed/35640989
http://dx.doi.org/10.9778/cmajo.20210180
work_keys_str_mv AT boodmancarl serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT wuerzterence serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT lagacewiensphilippe serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT lindsayrobbin serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT dibernardoantonia serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT bullardjared serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT steinderekr serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries
AT keynanyoav serologictestingforbartonellainmanitobacanada20102020aretrospectivecaseseries